The corporate's specialty product offshoot will house investment vehicle Solvay Ventures, Matt Jones and Coppelia Marincovic told Global Corporate Venturing.

Corporate venture capital (CVC) unit Solvay Ventures will be retained by one of the two publicly traded entities into which Belgium-based advanced materials and chemicals producer Solvay is set to divide.

The company announced the split last month, and Solvay Ventures will be transferred to an entity preliminary dubbed SpecialityCo, which will take on higher-growth, higher-margin businesses like specialty polymers, aroma chemicals, aerospace composites and assorted ingredients for consumer products.

The other side of the business, tentatively called EssentialCo, will…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.